Midazolam (Versed) Dosage and Administration Guidelines
For adult patients requiring sedation, the recommended initial dose of midazolam is 1-2 mg IV administered over 2 minutes, with titration in small increments to the desired effect, not exceeding 5 mg total dose in healthy adults under 60 years. 1
Adult Dosing Guidelines
Intravenous Administration
- Initial dose for healthy adults under 60 years: 1-2 mg (0.03 mg/kg) IV administered over 2 minutes 1
- Wait 2 or more minutes to evaluate sedative effect before administering additional doses 1
- Titrate in small increments (1 mg) until desired effect (e.g., slurred speech) 1
- Total dose rarely exceeds 5 mg in healthy adults 1
- For patients receiving opioids or other CNS depressants, reduce midazolam dose by approximately 30% 1
Special Populations
- Adults 60 years or older: Initial dose 1-1.5 mg IV over 2 minutes; total dose rarely exceeds 3.5 mg 1
- Debilitated or chronically ill patients: Reduce dose by 50% compared to healthy adults 1
- Patients with hepatic or renal impairment: Reduce dose due to decreased clearance 2
Intramuscular Administration
- Preoperative sedation: 0.07-0.08 mg/kg IM (approximately 5 mg) administered up to 1 hour before procedure 1
- Inject deep into large muscle mass 1
- Onset within 15 minutes, peak effect at 30-60 minutes 1
Continuous Infusion
- For critical care sedation: Initial IV loading dose of 0.05-0.2 mg/kg administered over 2-3 minutes 1
- Maintenance infusion: 0.06-0.12 mg/kg/hr (1-2 mcg/kg/min) 1
- Adjust rate by 25% of initial rate as needed based on clinical response 1
Pediatric Dosing
- 6 months to 5 years: Initial dose 0.05-0.1 mg/kg IV; total dose up to 0.6 mg/kg (not exceeding 6 mg) 1, 3
- 6-12 years: Initial dose 0.025-0.05 mg/kg IV; total dose up to 0.4 mg/kg (not exceeding 10 mg) 1, 3
- 12-16 years: Dose as adults 1
- For seizures: 0.05-0.1 mg/kg IV/IM (maximum 4 mg per dose), may repeat every 10-15 minutes if needed 2
Administration Precautions
- Always titrate slowly, administering over at least 2 minutes 1
- Allow 2 or more minutes between doses to fully evaluate sedative effect 1
- Ensure immediate availability of resuscitative equipment and personnel trained in airway management 1
- Monitor oxygen saturation continuously during administration 2
- Reduce dose when used with other CNS depressants, especially opioids 1
Potential Adverse Effects
- Respiratory depression and apnea, especially when combined with opioids 4, 5
- Hypotension, particularly in elderly, critically ill patients, or with rapid administration 1
- Paradoxical reactions including agitation, anxiety, and insomnia 6
- Hiccups, cough, nausea, and vomiting 4
Reversal Agent
- Flumazenil can reverse midazolam-induced sedation in emergency situations 7
- Typical flumazenil dose: 0.2-0.4 mg IV every 2-3 minutes until desired response 6
Clinical Pearls
- Midazolam is approximately 2-4 times more potent than diazepam 4, 8
- Half-life is approximately 1 hour in healthy adults but may be prolonged in renal or hepatic dysfunction 4
- Water-soluble in commercial formulation but becomes lipid-soluble at physiological pH, allowing rapid CNS penetration 3
- Metabolized by cytochrome P450 enzyme system; drug interactions possible with inhibitors like cimetidine 4
Remember that careful titration to clinical effect and close monitoring are essential for safe administration of midazolam in all patient populations.